nach oben

07.05.2024 | REVIEW

Cardiovascular Implications of Sleep Disorders Beyond Sleep Apnea

verfasst von: Jung-A Park, Jee-Eun Yoon, Xiaoyue Liu, Yoonhee Chang, Giuseppe Maiolino, Martino F. Pengo, Gen-min Lin, Younghoon Kwon

Erschienen in: Current Sleep Medicine Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Sleep is crucial for human health and life. There is still limited attention to the association between sleep disorders beyond sleep apnea and cardiovascular (CV) health. We investigated the current evidence between non-respiratory sleep disorders and CV health.

Recent findings

Current evidence suggests an important association between sleep duration, circadian rhythm, insomnia, disorders of hypersomnolence and CV health. Sleep-related movement disorders exhibit a moderate association with CV health. Further research is needed to explore the effects of each sleep disorder on CV health.

Summary

Given the close association between non-respiratory sleep disorders and CV health, it is crucial to recognize and address sleep disorders in patients with a high CV risk.

CDC: Adult Sleep Data. 2022. https://www.cdc.gov/sleep/data-and-statistics/Adults.html. Accessed September 20 2023.

CDC: Sleep and Sleep Disorders. 2023. https://www.cdc.gov/sleep/index.html. Accessed September 20 2023.

Wang S, Rossheim ME, Nandy RR. Trends in prevalence of short sleep duration and trouble sleeping among US adults, 2005–2018. Sleep. 2023;46(1):zsac231. https://doi.org/10.1093/sleep/zsac231.CrossRefPubMed

Metse AP, Clinton-McHarg T, Skinner E, Yogaraj Y, Colyvas K, Bowman J. Associations between suboptimal sleep and smoking, poor nutrition, harmful alcohol consumption and inadequate physical activity (‘snap risks’): a comparison of people with and without a mental health condition in an australian community survey. Int J Environ Res Public Health. 2021;18(11):5946. https://doi.org/10.3390/ijerph18115946.CrossRefPubMedPubMedCentral

• Cui H, Xu R, Wan Y, Ling Y, Jiang Y, Wu Y, et al. Relationship of sleep duration with incident cardiovascular outcomes: a prospective study of 33,883 adults in a general population. BMC Public Health. 2023;23(1):124. https://doi.org/10.1186/s12889-023-15042-x. (A study with a population-based cohort proved the longitudinal association of SD and incident CVD).CrossRefPubMedPubMedCentral

Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens. 1999;12(1):63–8. https://doi.org/10.1016/s0895-7061(98)00200-3.CrossRefPubMed

Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169(11):1055–61. https://doi.org/10.1001/archinternmed.2009.119.CrossRefPubMedPubMedCentral

Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29(8):1009–14. https://doi.org/10.1093/sleep/29.8.1009.CrossRefPubMed

Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev. 2016;30:11–24. https://doi.org/10.1016/j.smrv.2015.10.002.CrossRefPubMed

10.

Butler M, Spruill T, Johnson D, Redline S, Sims M, Jenkins B, et al. Suboptimal sleep and incident cardiovascular disease among African Americans in the Jackson Heart Study (JHS). Sleep Med. 2020;76:89–97. https://doi.org/10.1016/j.sleep.2020.09.005.CrossRefPubMedPubMedCentral

11.

Liu Y, Wheaton AG, Chapman DP, Croft JB. Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 behavioral risk factor surveillance system. Sleep. 2013;36(10):1421–7. https://doi.org/10.5665/sleep.3028.CrossRefPubMedPubMedCentral

12.

Antza C, Kostopoulos G, Mostafa S, Nirantharakumar K, Tahrani A. The links between sleep duration, obesity and type 2 diabetes mellitus. J Endocrinol. 2021;252(2):125–41. https://doi.org/10.1530/joe-21-0155.CrossRefPubMedPubMedCentral

13.

Bock JM, Vungarala S, Covassin N, Somers VK. Sleep duration and hypertension: epidemiological evidence and underlying mechanisms. Am J Hypertens. 2022;35(1):3–11. https://doi.org/10.1093/ajh/hpab146.CrossRefPubMed

14.

Grandner MA, Jackson NJ, Izci-Balserak B, Gallagher RA, Murray-Bachmann R, Williams NJ, et al. Social and Behavioral Determinants of Perceived Insufficient Sleep. Front Neurol. 2015;6:112. https://doi.org/10.3389/fneur.2015.00112.CrossRefPubMedPubMedCentral

15.

Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92. https://doi.org/10.1093/eurheartj/ehr007.CrossRefPubMed

16.

Baron KG, Duffecy J, Richardson D, Avery E, Rothschild S, Lane J. Technology assisted behavior intervention to extend sleep among adults with short sleep duration and prehypertension/stage 1 hypertension: a randomized pilot feasibility study. J Clin Sleep Med. 2019;15(11):1587–97. https://doi.org/10.5664/jcsm.8018.CrossRefPubMedPubMedCentral

17.

Pandey A, Littlewood K, Cooper L, Hernandez L, Day A. 1052 Pragmatic approaches for integrating healthy sleep hygiene to promote chronic disease management. Sleep. 2018;41(suppl_1):A391. https://doi.org/10.1093/sleep/zsy061.1051.CrossRef

18.

Harrison EI, Roth RH, Lobo JM, Kang H, Logan J, Patel SR, et al. Sleep time and efficiency in patients undergoing laboratory-based polysomnography. J Clin Sleep Med. 2021;17(8):1591–8. https://doi.org/10.5664/jcsm.9252.CrossRefPubMedPubMedCentral

19.

van der Zweerde T, Bisdounis L, Kyle SD, Lancee J. VU research portal. Sleep Med Rev. 2019;48:101208. https://doi.org/10.1016/j.smrv.2019.08.002.CrossRefPubMed

20.

Sateia MJ (2014) International classification of sleep disorders. Chest 146(5):1387–1394. https://doi.org/10.1378/chest.14-0970

21.

Li Y, Zhang X, Winkelman JW, Redline S, Hu FB, Stampfer M, et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014;129(7):737–46. https://doi.org/10.1161/circulationaha.113.004500.CrossRefPubMed

22.

Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011;124(19):2073–81. https://doi.org/10.1161/circulationaha.111.025858.CrossRefPubMed

23.

Hsu CY, Chen YT, Chen MH, Huang CC, Chiang CH, Huang PH, et al. The association between insomnia and increased future cardiovascular events: a nationwide population-based study. Psychosom Med. 2015;77(7):743–51. https://doi.org/10.1097/psy.0000000000000199.CrossRefPubMed

24.

Chen CC, Lin CH, Yang TY, Wang TJ, Li SJ, Fang YA, et al. Association between sleep disorder and atrial fibrillation: A nationwide population-based cohort study. Sleep Med. 2022;96:50–6. https://doi.org/10.1016/j.sleep.2022.05.002.CrossRefPubMed

25.

Lee HH, Chen YC, Chen JJ, Lo SH, Guo YL, Hu HY. Insomnia and the risk of atrial fibrillation: a population-based cohort study. Acta Cardiol Sin. 2017;33(2):165–72. https://doi.org/10.6515/acs20160611b.CrossRefPubMedPubMedCentral

26.

Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014;35(21):1382–93. https://doi.org/10.1093/eurheartj/eht019.CrossRefPubMed

27.

Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57–64. https://doi.org/10.1177/2047487312460020.CrossRefPubMed

28.

Parthasarathy S, Vasquez MM, Halonen M, Bootzin R, Quan SF, Martinez FD, et al. Persistent insomnia is associated with mortality risk. Am J Med. 2015;128(3):268-75.e2. https://doi.org/10.1016/j.amjmed.2014.10.015.CrossRefPubMed

29.

Javaheri S, Redline S. Insomnia and Risk of Cardiovascular Disease. Chest. 2017;152(2):435–44. https://doi.org/10.1016/j.chest.2017.01.026.CrossRefPubMedPubMedCentral

30.

Castro-Diehl C, Diez Roux AV, Redline S, Seeman T, McKinley P, Sloan R, et al. Sleep duration and quality in relation to autonomic nervous system measures: the multi-ethnic study of atherosclerosis (MESA). Sleep. 2016;39(11):1927–40. https://doi.org/10.5665/sleep.6218.CrossRefPubMedPubMedCentral

31.

Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86(8):3787–94. https://doi.org/10.1210/jcem.86.8.7778.CrossRefPubMed

32.

Castro-Diehl C, Diez Roux AV, Redline S, Seeman T, Shrager SE, Shea S. Association of sleep duration and quality with alterations in the hypothalamic-pituitary adrenocortical axis: the multi-ethnic study of atherosclerosis (MESA). J Clin Endocrinol Metab. 2015;100(8):3149–58. https://doi.org/10.1210/jc.2015-1198.CrossRefPubMedPubMedCentral

33.

Wang X, Zhao C, Feng H, Li G, He L, Yang L, et al. Associations of insomnia with insulin resistance traits: a cross-sectional and mendelian randomization study. J Clin Endocrinol Metab. 2023;108(8):e574–82. https://doi.org/10.1210/clinem/dgad089.CrossRefPubMed

34.

Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009;32(11):1980–5. https://doi.org/10.2337/dc09-0284.CrossRefPubMedPubMedCentral

35.

Shivashankar R, Kondal D, Ali MK, Gupta R, Pradeepa R, Mohan V, Kadir MM, Narayan KMV, Tandon N, Prabhakaran D, Peasey A (2017) Associations of sleep duration and disturbances with hypertension in Metropolitan Cities of Delhi, Chennai, and Karachi in South Asia: Cross-Sectional Analysis of the CARRS study. Sleep 40(9):zsx119. https://doi.org/10.1093/sleep/zsx119

36.

Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60(4):929–35. https://doi.org/10.1161/hypertensionaha.112.193268.CrossRefPubMed

37.

Gangwisch JE, Malaspina D, Posner K, Babiss LA, Heymsfield SB, Turner JB, et al. Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens. 2010;23(1):62–9. https://doi.org/10.1038/ajh.2009.202.CrossRefPubMed

38.

Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491–7. https://doi.org/10.1093/sleep/32.4.491.CrossRefPubMedPubMedCentral

39.

Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45(6):344–50. https://doi.org/10.1539/joh.45.344.CrossRefPubMed

40.

• Maiolino G, Bisogni V, Soranna D, Pengo MF, Pucci G, Vettor R, et al. Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis. Sleep Med Rev. 2021;59:101497. https://doi.org/10.1016/j.smrv.2021.101497. (This systematic review and meta-analysis studied the association between insomnia and BP).CrossRefPubMed

41.

Yang WY, Melgarejo JD, Thijs L, Zhang ZY, Boggia J, Wei FF, et al. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes. JAMA. 2019;322(5):409–20. https://doi.org/10.3410/f.736356370.793563923.CrossRefPubMedPubMedCentral

42.

• Savin KL, Clark TL, Perez-Ramirez P, Allen TS, Tristão Parra M, Gallo LC. The effect of cognitive behavioral therapy for insomnia (CBT-I) on Cardiometabolic health biomarkers: a systematic review of randomized controlled trials. Behav Sleep Med. 2023;21(6):671–94. https://doi.org/10.1080/15402002.2022.2154213. (This study investigated the effectiveness of CBT-I on CV health).CrossRefPubMed

43.

Johann AF, Hertenstein E, Feige B, Akram U, Holub F, Baglioni C, et al. Cognitive behavioural therapy for insomnia does not appear to have a substantial impact on early markers of cardiovascular disease: A preliminary randomized controlled trial. J Sleep Res. 2020;29(5): e13102. https://doi.org/10.1111/jsr.13102.CrossRefPubMed

44.

Barateau L, Dauvilliers Y (2023) Cardiovascular burden of narcolepsy: what have we learned and what do we still need to know? Sleep 46(10):zsad213. https://doi.org/10.1093/sleep/zsad213

45.

Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14(6):488–92. https://doi.org/10.1016/j.sleep.2013.03.002.CrossRefPubMed

46.

Black J, Reaven N, Funk S, McGaughey K, Ohayon M, Guilleminault C, et al. Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study. Sleep Med. 2017;33:13–8. https://doi.org/10.1016/j.sleep.2016.04.004.CrossRefPubMed

47.

• Ben-Joseph RH, Saad R, Black J, Dabrowski EC, Taylor B, Gallucci S, et al. Cardiovascular burden of narcolepsy disease (CV-BOND): a real-world evidence study. Sleep. 2023;46(10):161. https://doi.org/10.1093/sleep/zsad161. (A most recent study proved the temporal relationship between narcolepsy and new-onset CVD).CrossRef

48.

Tao Y, Luo J, Xu Y, Wang H, Tian J, Yang S, et al. Narcolepsy and cardiovascular disease: A two-sample Mendelian randomization study. Sleep Med. 2023;113:6–12. https://doi.org/10.1016/j.sleep.2023.10.029.CrossRefPubMed

49.

Saad R, Lillaney P, Profant D, Fuller DS, Alvord T, Prince P, et al. EPH231 cardiovascular burden of patients diagnosed with idiopathic hypersomnia: real-world idiopathic hypersomnia total health model (CV-RHYTHM). Value in Health. 2023;26(6):S205. https://doi.org/10.1016/j.jval.2023.03.2577.CrossRef

50.

Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. J Am Geriatrics Soc. 2000;48(2):115–23. https://doi.org/10.1111/j.1532-5415.2000.tb03901.x.CrossRef

51.

Goodman MO, Dashti HS, Lane JM, Windred DP, Burns A, Jones SE, et al. Causal association between subtypes of excessive daytime sleepiness and risk of cardiovascular diseases. J Am Heart Assoc. 2023;12:e030568. https://doi.org/10.1161/jaha.122.030568.CrossRefPubMedPubMedCentral

52.

Bock J, Covassin N, Somers V. Excessive daytime sleepiness: an emerging marker of cardiovascular risk. Heart. 2022;108(22):1761–6. https://doi.org/10.1136/heartjnl-2021-319596.CrossRefPubMed

53.

Vandi S, Rodolfi S, Pizza F, Moresco M, Antelmi E, Ferri R, et al. Cardiovascular autonomic dysfunction, altered sleep architecture, and muscle overactivity during nocturnal sleep in pediatric patients with narcolepsy type 1. Sleep. 2019;42(12):zsz169. https://doi.org/10.1093/sleep/zsz169.CrossRefPubMed

54.

Stiefel G, Besag FMC. Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Saf. 2010;33(10):821–42. https://doi.org/10.2165/11536380-000000000-00000.CrossRefPubMed

55.

Jennum PJ, Plazzi G, Silvani A, Surkin LA, Dauvilliers Y. Cardiovascular disorders in narcolepsy: review of associations and determinants. Sleep Med Rev. 2021;58:101440. https://doi.org/10.1016/j.smrv.2021.101440.CrossRefPubMed

56.

Brown TM, Piggins HD. Electrophysiology of the suprachiasmatic circadian clock. Prog Neurobiol. 2007;82(5):229–55. https://doi.org/10.1016/j.pneurobio.2007.05.002.CrossRefPubMed

57.

Crnko S, Du Pré BC, Sluijter JP, Van Laake LW. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat Rev Cardiol. 2019;16(7):437–47. https://doi.org/10.1038/s41569-019-0167-4.CrossRefPubMed

58.

Middlekauff HR, Sontz EM. Morning sympathetic nerve activity is not increased in humans: implications for mechanisms underlying the circadian pattern of cardiac risk. Circulation. 1995;91(10):2549–55. https://doi.org/10.1161/01.cir.91.10.2549.CrossRefPubMed

59.

Holmes DR Jr, Aguirre FV, Aplin R, Lennon RJ, Nestler DM, Bell MR, et al. Circadian rhythms in patients with ST-elevation myocardial infarction. Circulation: Cardiovasc Qual Outcomes. 2010;3(4):382–9. https://doi.org/10.1161/CIRCOUTCOMES.109.913343.CrossRef

60.

Takeda N, Maemura K, Horie S, Oishi K, Imai Y, Harada T, et al. Thrombomodulin is a clock-controlled gene in vascular endothelial cells. J Biol Chem. 2007;282(45):32561–7. https://doi.org/10.1074/jbc.m705692200.CrossRefPubMed

61.

Black N, D’Souza A, Wang Y, Piggins H, Dobrzynski H, Morris G, et al. Circadian rhythm of cardiac electrophysiology, arrhythmogenesis, and the underlying mechanisms. Heart Rhythm. 2019;16(2):298–307. https://doi.org/10.1016/j.hrthm.2018.08.026.CrossRefPubMedPubMedCentral

62.

Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29(5):992–6. https://doi.org/10.1161/01.str.29.5.992.CrossRefPubMed

63.

Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987;60(10):801–6. https://doi.org/10.1016/0002-9149(87)91027-7.CrossRefPubMed

64.

Reutrakul S, Knutson KL. Consequences of circadian disruption on cardiometabolic health. Sleep Med Clin. 2015;10(4):455–68. https://doi.org/10.1016/j.jsmc.2015.07.005.CrossRefPubMedPubMedCentral

65.

Guo Y, Liu Y, Huang X, Rong Y, He M, Wang Y, et al. The effects of shift work on sleeping quality, hypertension and diabetes in retired workers. PLoS ONE. 2013;8(8):e71107. https://doi.org/10.1371/journal.pone.0071107.CrossRefPubMedPubMedCentral

66.

Sakata K, Suwazono Y, Harada H, Okubo Y, Kobayashi E, Nogawa K. The relationship between shift work and the onset of hypertension in male Japanese workers. J Occup Environ Med. 2003;45:1002–6. https://doi.org/10.1097/01.jom.0000085893.98441.96.CrossRefPubMed

67.

Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE, et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation. 1995;92(11):3178–82. https://doi.org/10.1161/01.cir.92.11.3178.CrossRefPubMed

68.

Rutters F, Lemmens SG, Adam TC, Bremmer MA, Elders PJ, Nijpels G, et al. Is social jetlag associated with an adverse endocrine, behavioral, and cardiovascular risk profile? J Biol Rhythms. 2014;29(5):377–83. https://doi.org/10.1177/0748730414550199.CrossRefPubMed

69.

Merikanto I, Lahti T, Puolijoki H, Vanhala M, Peltonen M, Laatikainen T, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30(4):470–7. https://doi.org/10.3109/07420528.2012.741171.CrossRefPubMed

70.

Kramer A, Lange T, Spies C, Finger A-M, Berg D, Oster H. Foundations of circadian medicine. PLoS Biol. 2022;20(3):e3001567. https://doi.org/10.1371/journal.pbio.3001567.CrossRefPubMedPubMedCentral

71.

Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629–51. https://doi.org/10.3109/07420528.2010.510230.CrossRefPubMed

72.

Chellappa SL, Qian J, Vujovic N, Morris CJ, Nedeltcheva A, Nguyen H, et al. Daytime eating prevents internal circadian misalignment and glucose intolerance in night work. Sci Adv. 2021;7(49):eabg9910. https://doi.org/10.1126/sciadv.abg9910.CrossRefPubMedPubMedCentral

73.

Racca C, van Diemen JJK, Fuijkschot WW, Spit K, Bonten TN, Numans ME, et al. Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours. Platelets. 2019;30(7):871–7. https://doi.org/10.1080/09537104.2018.1528347.CrossRefPubMed

74.

Huang T-C, Tseng P-T, Wu M-N, Stubbs B, Carvalho AF, Lin P-Y, et al. Periodic limb movements during sleep are associated with cardiovascular diseases: A systematic review and meta-analysis. J Sleep Res. 2019;28(3):e12720. https://doi.org/10.1111/jsr.12720.CrossRefPubMed

75.

Silber MH, Buchfuhrer MJ, Earley CJ, Koo BB, Manconi M, Winkelman JW, et al. The management of restless legs syndrome: an updated algorithm. Mayo Clin Proc. 2021;96(7):1921–37. https://doi.org/10.1016/j.mayocp.2020.12.026.CrossRefPubMed

76.

Almuwaqqat Z, Kim JH, Islam SJ, Mehta A, Ahmad S, Wehbe M, et al. Usefulness of restless legs symptoms to predict adverse cardiovascular outcomes in men with coronary artery disease. Am J Cardiol. 2022;162:41–8. https://doi.org/10.1016/j.amjcard.2021.08.054.CrossRefPubMed

77.

Hein M, Lanquart J-P, Hubain P, Loas G. Risk of resistant hypertension associated with restless legs syndrome and periodic limb movements during sleep: a study on 673 treated hypertensive individuals. Sleep Med. 2019;63:46–56. https://doi.org/10.1016/j.sleep.2019.05.013.CrossRefPubMed

78.

Li Y, Li Y, Winkelman JW, Walters AS, Han J, Hu FB, et al. Prospective study of restless legs syndrome and total and cardiovascular mortality among women. Neurology. 2018;90(2):e135–41. https://doi.org/10.1212/wnl.0000000000004814.CrossRefPubMedPubMedCentral

79.

Juuti A, Läärä E, Rajala U, Laakso M, Härkönen P, Keinänen-Kiukaanniemi S, et al. Prevalence and associated factors of restless legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand. 2010;122(1):63–9. https://doi.org/10.1111/j.1600-0404.2009.01262.x.CrossRefPubMed

80.

Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35–42. https://doi.org/10.1212/01.wnl.0000287072.93277.c9.CrossRefPubMed

81.

Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7(7):545–52. https://doi.org/10.1016/j.sleep.2006.01.004.CrossRefPubMed

82.

• Gao X, Ba DM, Bagai K, Liu G, Ma C, Walters AS. Treating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort study with 34 years of follow-Up. J Am Heart Assoc. 2021;10(4):e018674. https://doi.org/10.1161/JAHA.120.018674. (This is the first study which proved the appropriate treatment of RLS lowers the CV risks).CrossRefPubMedPubMedCentral

83.

Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, et al. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open. 2012;2(2):e000866. https://doi.org/10.1136/bmjopen-2012-000866.CrossRefPubMedPubMedCentral

84.

Winter AC, Berger K, Glynn RJ, Buring JE, Gaziano JM, Schürks M, et al. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med. 2013;126(3):228-35.e2. https://doi.org/10.1016/j.amjmed.2012.06.039.CrossRefPubMedPubMedCentral

85.

Cholley-Roulleau M, Chenini S, Béziat S, Guiraud L, Jaussent I, Dauvilliers Y. Restless legs syndrome and cardiovascular diseases: a case-control study. PLoS ONE. 2017;12(4):e0176552. https://doi.org/10.1371/journal.pone.0176552.CrossRefPubMedPubMedCentral

86.

Gottlieb DJ, Somers VK, Punjabi NM, Winkelman JW. Restless legs syndrome and cardiovascular disease: a research roadmap. Sleep Med. 2017;31:10–7. https://doi.org/10.1016/j.sleep.2016.08.008.CrossRefPubMed

87.

Von Haehling S, Jankowska EA, Van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015;12(11):659–69. https://doi.org/10.1038/nrcardio.2015.109.CrossRef

88.

Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–5. https://doi.org/10.1002/mds.870120111.CrossRefPubMed

89.

Sforza E, Roche F, Pichot V. Determinants of nocturnal cardiovascular variability and heart rate arousal response in restless legs syndrome (RLS)/Periodic limb movements (PLMS). J Clin Med. 2019;8(10):1619. https://doi.org/10.3390/jcm8101619.CrossRefPubMedPubMedCentral

90.

Winkelman JW. The Evoked Heart Rate Response to Periodic Leg Movements of Sleep. Sleep. 1999;22(5):575–80. https://doi.org/10.1093/sleep/22.5.575.CrossRefPubMed

91.

Pennestri M-H, Montplaisir J, Fradette L, Lavigne G, Colombo R, Lanfranchi PA. Blood pressure changes associated with periodic leg movements during sleep in healthy subjects. Sleep Med. 2013;14(6):555–61. https://doi.org/10.1016/j.sleep.2013.02.005.CrossRefPubMed

92.

Koo BB, Blackwell T, Ancoli-Israel S, Stone KL, Stefanick ML, Redline S. Association of incident cardiovascular disease with periodic limb movements during sleep in older men. Circulation. 2011;124(11):1223–31. https://doi.org/10.1161/CIRCULATIONAHA.111.038968.CrossRefPubMedPubMedCentral

93.

Koo BB, Mehra R, Blackwell T, Ancoli-Israel S, Stone KL, Redline S, et al. Periodic limb movements during sleep and cardiac arrhythmia in older men (MrOS sleep). J Clin Sleep Med. 2014;10(1):7–11. https://doi.org/10.5664/jcsm.3346.CrossRefPubMedPubMedCentral

94.

May AM, May RD, Bena J, Wang L, Monahan K, Stone KL, et al. Individual periodic limb movements with arousal are temporally associated with nonsustained ventricular tachycardia: a case-crossover analysis. Sleep. 2019;42(11):zsz165. https://doi.org/10.1093/sleep/zsz165.CrossRefPubMedPubMedCentral

95.

Wipper B, Winkelman JW. The long-term psychiatric and cardiovascular morbidity and mortality of restless legs syndrome and periodic limb movements of sleep. Sleep Med Clin. 2021;16(2):279–88. https://doi.org/10.1016/j.jsmc.2021.02.005.CrossRefPubMed

96.

Kang S-H, Yoon I-Y, Lee SD, Han JW, Kim TH, Kim KW. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;36(8):1147–52. https://doi.org/10.5665/sleep.2874.CrossRefPubMedPubMedCentral

97.

Haba-Rubio J, Frauscher B, Marques-Vidal P, Toriel J, Tobback N, Andries D, et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep. 2018;41(2):zsx197. https://doi.org/10.1093/sleep/zsx197.CrossRefPubMed

98.

Sasai-Sakuma T, Takeuchi N, Asai Y, Inoue Y, Inoue Y (2020) Prevalence and clinical characteristics of REM sleep behavior disorder in Japanese elderly people. Sleep 43(8):zsaa024. https://doi.org/10.1093/sleep/zsaa024

99.

• Zhang X, Molsberry SA, Pavlova M, Schwarzschild MA, Ascherio A, Gao X. Probable Parasomnias and Mortality: A Prospective Study in US Men. Mayo Clin Proc. 2023;98(10):1449–57. https://doi.org/10.1016/j.mayocp.2023.06.018. (Thisstudywithlarge-populationfoundthatprobableparasomniawasassociatedwithanincreasedriskofall-causemortality).CrossRefPubMed

100.

Terzaghi M, Pilati L, Ghiotto N, Arnaldi D, Versino M, Rustioni V, et al. Twenty-four-hour blood pressure profile in idiopathic REM sleep behavior disorder. Sleep. 2022;45(2):zsab239. https://doi.org/10.1093/sleep/zsab239.CrossRefPubMed

101.

Frauscher B, Jennum P, Ju Y-ES, Postuma RB, Arnulf I, Cochen De Cock V, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;82(12):1076–9. https://doi.org/10.1212/WNL.0000000000000247.CrossRefPubMedPubMedCentral

102.

Wong JC, Li J, Pavlova M, Chen S, Wu A, Wu S, et al. Risk factors for probable REM sleep behavior disorder: a community-based study. Neurology. 2016;86(14):1306–12. https://doi.org/10.1212/WNL.0000000000002414.CrossRefPubMedPubMedCentral

103.

Lanfranchi PA, Fradette L, Gagnon J-F, Colombo R, Montplaisir J. Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder. Sleep. 2007;30(8):1019–25. https://doi.org/10.1093/sleep/30.8.1019.CrossRefPubMedPubMedCentral

104.

Mahowald MW, Schenck CH. REM sleep behaviour disorder: a marker of synucleinopathy. The Lancet Neurology. 2013;12(5):417–9. https://doi.org/10.1016/S1474-4422(13)70078-4.CrossRefPubMed

105.

Mendoza-Velásquez JJ, Flores-Vázquez JF, Barrón-Velázquez E, Sosa-Ortiz AL, Illigens B-MW, Siepmann T. Autonomic dysfunction in α-synucleinopathies. Front Neurol. 2019;10:363. https://doi.org/10.3389/fneur.2019.00363.CrossRefPubMedPubMedCentral

106.

Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, et al. Baseline characteristics of the North American prodromal Synucleinopathy cohort. Ann Clin Transl Neurol. 2023;10(4):520–35. https://doi.org/10.1002/acn3.51738.CrossRefPubMedPubMedCentral

107.

Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of Atrial Fibrillation in the 21st Century. Circ Res. 2020;127(1):4–20. https://doi.org/10.1161/CIRCRESAHA.120.316340.CrossRefPubMedPubMedCentral

108.

Kwon Y, Koene RJ, Johnson AR, Lin GM, Ferguson JD. Sleep, sleep apnea and atrial fibrillation: Questions and answers. Sleep Med Rev. 2018;39:134–42. https://doi.org/10.1016/j.smrv.2017.08.005.CrossRefPubMed

109.

Christensen MA, Dixit S, Dewland TA, Whitman IR, Nah G, Vittinghoff E, et al. Sleep characteristics that predict atrial fibrillation. Heart Rhythm. 2018;15(9):1289–95. https://doi.org/10.1016/j.hrthm.2018.05.008.CrossRefPubMedPubMedCentral

110.

Gaffey AE, Rosman L, Lampert R, Yaggi HK, Haskell SG, Brandt CA, et al. Insomnia and early incident atrial fibrillation: a 16-year cohort study of younger men and women veterans. J Am Heart Assoc. 2023;12(20):e030331. https://doi.org/10.1161/jaha.123.030331.CrossRefPubMedPubMedCentral

111.

Kwon Y, Gharib SA, Biggs ML, Jacobs DR Jr, Alonso A, Duprez D, et al. Association of sleep characteristics with atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2015;70(9):873–9. https://doi.org/10.1136/thoraxjnl-2014-206655.CrossRefPubMed

112.

Morovatdar N, Ebrahimi N, Rezaee R, Poorzand H, Bayat Tork MA, Sahebkar A. Sleep Duration and Risk of Atrial Fibrillation: a Systematic Review. J Atr Fibrillation. 2019;11(6):2132. https://doi.org/10.4022/jafib.2132.CrossRefPubMedPubMedCentral

113.

Zhao J, Yang F, Zhuo C, Wang Q, Qu Z, Wang Q, et al. Association of sleep duration with atrial fibrillation and heart failure: a mendelian randomization analysis. Front Genet. 2021;12:583658. https://doi.org/10.3389/fgene.2021.583658.CrossRefPubMedPubMedCentral

114.

Kwon Y, Gadi S, Shah NR, Stout C, Blackwell JN, Cho Y, et al. Atrial fibrillation and objective sleep quality by slow wave sleep. J Atr Fibrillation. 2018;11(2):2031. https://doi.org/10.4022/jafib.2031.CrossRefPubMedPubMedCentral

Titel: Cardiovascular Implications of Sleep Disorders Beyond Sleep Apnea
verfasst von: Jung-A Park
Jee-Eun Yoon
Xiaoyue Liu
Yoonhee Chang
Giuseppe Maiolino
Martino F. Pengo
Gen-min Lin
Younghoon Kwon
Publikationsdatum: 07.05.2024
Verlag: Springer International Publishing
Erschienen in: Current Sleep Medicine Reports
Elektronische ISSN: 2198-6401
DOI: https://doi.org/10.1007/s40675-024-00302-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen